Literature DB >> 26489798

Role of the single deaminase domain APOBEC3A in virus restriction, retrotransposition, DNA damage and cancer.

Yaqiong Wang1, Kimberly Schmitt1, Kejun Guo2, Mario L Santiago2, Edward B Stephens1.   

Abstract

The apolipoprotein mRNA editing enzyme catalytic polypeptide-like 3 (APOBEC3; A3) proteins are a family of seven cytidine deaminases (A3A, A3B, A3C, A3D, A3F, A3G and A3H) that restrict certain viral infections. These innate defence factors are best known for their ability to restrict the replication of human immunodeficiency virus type 1 (HIV-1) lacking a functional Vif protein (HIV-1Δvif) through the deamination of cytidine residues to uridines during reverse transcription, ultimately leading to lethal G → A changes in the viral genome. The best studied of the A3 proteins has been APOBEC3G because of its potent activity against HIV-1Δvif. However, one member of this family, A3A, has biological properties that make it unique among the A3 proteins. In this review, we will focus on the structural and phylogenetic features of the human and non-human primate A3A proteins, their role in the restriction of retroviruses and other viruses, and current findings on other biological properties affected by this protein.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26489798      PMCID: PMC5972328          DOI: 10.1099/jgv.0.000320

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  153 in total

1.  An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22.

Authors:  Adam Jarmuz; Ann Chester; Jayne Bayliss; Jane Gisbourne; Ian Dunham; James Scott; Naveenan Navaratnam
Journal:  Genomics       Date:  2002-03       Impact factor: 5.736

2.  APOBEC3G DNA deaminase acts processively 3' --> 5' on single-stranded DNA.

Authors:  Linda Chelico; Phuong Pham; Peter Calabrese; Myron F Goodman
Journal:  Nat Struct Mol Biol       Date:  2006-04-23       Impact factor: 15.369

3.  The APOBEC3C crystal structure and the interface for HIV-1 Vif binding.

Authors:  Shingo Kitamura; Hirotaka Ode; Masaaki Nakashima; Mayumi Imahashi; Yuriko Naganawa; Teppei Kurosawa; Yoshiyuki Yokomaku; Takashi Yamane; Nobuhisa Watanabe; Atsuo Suzuki; Wataru Sugiura; Yasumasa Iwatani
Journal:  Nat Struct Mol Biol       Date:  2012-09-23       Impact factor: 15.369

4.  A prevalent cancer susceptibility APOBEC3A hybrid allele bearing APOBEC3B 3'UTR enhances chromosomal DNA damage.

Authors:  Vincent Caval; Rodolphe Suspène; Milana Shapira; Jean-Pierre Vartanian; Simon Wain-Hobson
Journal:  Nat Commun       Date:  2014-10-09       Impact factor: 14.919

Review 5.  Historical perspective of foamy virus epidemiology and infection.

Authors:  C D Meiering; M L Linial
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

Review 6.  Genetic variants in urinary bladder cancer: collective power of the "wimp SNPs".

Authors:  Klaus Golka; Silvia Selinski; Marie-Louise Lehmann; Meinolf Blaszkewicz; Rosemarie Marchan; Katja Ickstadt; Holger Schwender; Hermann M Bolt; Jan G Hengstler
Journal:  Arch Toxicol       Date:  2011-03-05       Impact factor: 5.153

7.  APOBEC3B is an enzymatic source of mutation in breast cancer.

Authors:  Michael B Burns; Lela Lackey; Michael A Carpenter; Anurag Rathore; Allison M Land; Brandon Leonard; Eric W Refsland; Delshanee Kotandeniya; Natalia Tretyakova; Jason B Nikas; Douglas Yee; Nuri A Temiz; Duncan E Donohue; Rebecca M McDougle; William L Brown; Emily K Law; Reuben S Harris
Journal:  Nature       Date:  2013-02-06       Impact factor: 49.962

8.  A patch of positively charged amino acids surrounding the human immunodeficiency virus type 1 Vif SLVx4Yx9Y motif influences its interaction with APOBEC3G.

Authors:  Gongying Chen; Zhiwen He; Tao Wang; Rongzhen Xu; Xiao-Fang Yu
Journal:  J Virol       Date:  2009-06-17       Impact factor: 5.103

9.  Enzymatically active APOBEC3G is required for efficient inhibition of human immunodeficiency virus type 1.

Authors:  Eri Miyagi; Sandrine Opi; Hiroaki Takeuchi; Mohammad Khan; Ritu Goila-Gaur; Sandra Kao; Klaus Strebel
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

10.  Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G.

Authors:  Sara L Sawyer; Michael Emerman; Harmit S Malik
Journal:  PLoS Biol       Date:  2004-07-20       Impact factor: 8.029

View more
  8 in total

1.  Mechanism for APOBEC3G catalytic exclusion of RNA and non-substrate DNA.

Authors:  William C Solomon; Wazo Myint; Shurong Hou; Tapan Kanai; Rashmi Tripathi; Nese Kurt Yilmaz; Celia A Schiffer; Hiroshi Matsuo
Journal:  Nucleic Acids Res       Date:  2019-08-22       Impact factor: 16.971

2.  The Cytidine Deaminase APOBEC3 Family Is Subject to Transcriptional Regulation by p53.

Authors:  Daniel Menendez; Thuy-Ai Nguyen; Joyce Snipe; Michael A Resnick
Journal:  Mol Cancer Res       Date:  2017-02-23       Impact factor: 5.852

3.  Single-Molecule Force Spectroscopy Studies of APOBEC3A-Single-Stranded DNA Complexes.

Authors:  Luda S Shlyakhtenko; Samrat Dutta; Ming Li; Reuben S Harris; Yuri L Lyubchenko
Journal:  Biochemistry       Date:  2016-05-19       Impact factor: 3.162

4.  Deamination hotspots among APOBEC3 family members are defined by both target site sequence context and ssDNA secondary structure.

Authors:  Yumeng Z McDaniel; Dake Wang; Robin P Love; Madison B Adolph; Nazanin Mohammadzadeh; Linda Chelico; Louis M Mansky
Journal:  Nucleic Acids Res       Date:  2020-02-20       Impact factor: 16.971

5.  Human Papillomavirus 16 E7 Stabilizes APOBEC3A Protein by Inhibiting Cullin 2-Dependent Protein Degradation.

Authors:  Joseph A Westrich; Cody J Warren; Michael J Klausner; Kejun Guo; Chang-Wei Liu; Mario L Santiago; Dohun Pyeon
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

6.  A unique subset of low-risk Wilms tumors is characterized by loss of function of TRIM28 (KAP1), a gene critical in early renal development: A Children's Oncology Group study.

Authors:  Amy E Armstrong; Samantha Gadd; Vicki Huff; Daniela S Gerhard; Jeffrey S Dome; Elizabeth J Perlman
Journal:  PLoS One       Date:  2018-12-13       Impact factor: 3.240

7.  Early reduction of SARS-CoV-2-replication in bronchial epithelium by kinin B2 receptor antagonism.

Authors:  Constanze A Jakwerth; Martin Feuerherd; Ulrich M Zissler; Adam M Chaker; Ferdinand M Guerth; Madlen Oelsner; Linda Schellhammer; Johanna Giglberger; Lisa Pechtold; Claudia Jerin; Luisa Kugler; Carolin Mogler; Bernhard Haller; Anna Erb; Barbara Wollenberg; Christoph D Spinner; Thorsten Buch; Ulrike Protzer; Carsten B Schmidt-Weber
Journal:  J Mol Med (Berl)       Date:  2022-03-05       Impact factor: 4.599

Review 8.  Insights into the Structures and Multimeric Status of APOBEC Proteins Involved in Viral Restriction and Other Cellular Functions.

Authors:  Xiaojiang S Chen
Journal:  Viruses       Date:  2021-03-17       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.